• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation

	Wellgistics Health, Inc. (WGRX)
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date		2025-Sep-30	2025-Jun-30	2025-Mar-31	2024-Dec-31
Fiscal Period		Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024
Total Revenue		3,012,904$	7,790,865$	10,863,443$	12,410,423$	5,673,868$	44,540$
QoQ%		(61.33%)	(28.28%)	(12.47%)	118.73%	12,638.82%
YoY%		(46.90%)	17,391.84%
Cost Of Revenue		2,781,892$	7,285,113$	10,170,802$	11,161,745$	5,152,624$	47,148$
Gross Profit		231,012$	505,752$	692,641$	1,248,678$	521,244$	(2,608$)
Gross Margin		7.67%	6.49%	6.38%	10.06%	9.19%	(5.86%)
Operating Expenses		31,779,341$	6,006,128$	32,041,009$	4,996,210$	2,266,064$	570,408$	79,764$
Operating Income		(31,548,329$)	(5,500,376$)	(31,348,368$)	(3,747,532$)	(1,744,820$)	(573,016$)	(79,764$)
Operating Margin		(1,047.11%)	(70.60%)	(288.57%)	(30.20%)	(30.75%)	(1,286.52%)
Interest Income
Interest Expenses
Income Before Tax		(34,318,204$)	(6,672,464$)	(32,430,903$)	(4,331,752$)	(1,867,027$)	(574,325$)	(83,122$)
Tax Expenses
Net Income		(34,318,204$)	(6,672,464$)	(32,430,903$)	(4,331,752$)	(1,867,027$)	(574,325$)	(83,122$)
Profit Margin		(1,139.04%)	(85.65%)	(298.53%)	(34.90%)	(32.91%)	(1,289.46%)
TTM		(228.17%)	(123.31%)	(135.22%)
Earnings to Minority
Earnings to Common Shareholders		(34,318,204$)	(6,672,464$)	(32,430,903$)	(4,331,752$)	(1,867,027$)	(574,325$)	(83,122$)
QoQ%		(414.33%)	79.43%	(648.68%)	(132.01%)	(225.08%)	(590.94%)
YoY%		(1,738.12%)	(1,061.79%)	(38,916.03%)
Earnings Per Share, Basic		(0.46$)	(0.11$)	(0.62$)	(0.09$)	(0.04$)	(0.01$)	0.00$
Earnings Per Share, Diluted		(0.46$)	(0.11$)	(0.62$)	(0.09$)	(0.04$)	(0.01$)	0.00$
Unlevered FCF Per Share, Basic		(0.02$)	(0.03$)	(0.03$)	(0.05$)	0.02$	0.01$	0.00$
Unlevered FCF Per Share, Diluted		(0.02$)	(0.03$)	(0.03$)	(0.05$)	0.02$	0.01$	0.00$
Average Shares, Basic		74,379,403	61,771,127	51,916,787	49,986,374	48,403,775	45,898,175	44,720,000
Average Shares, Diluted		74,379,403	61,771,127	51,916,787	49,986,374	48,403,775	45,898,175	44,720,000
EBIT		(34,318,204$)	(6,672,464$)	(32,430,903$)	(4,331,752$)	(1,867,027$)	(574,325$)	(83,122$)
EBITDA		(33,515,410$)	(5,869,668$)	(31,628,031$)	(3,684,511$)	(1,399,604$)	(574,325$)	(83,122$)

Copy Table ✓